Publication | Closed Access

Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway

InflammationNetwork PharmacologyFibrosisInflammatory Lung DiseaseLung InflammationMedicineImmunologyPulmonary PharmacologyPulmonary FibrosisJia-wei-bu-shen-yi-qi FormulaPharmacologyCell SignalingVitro Reveal